FBRX · Categories · Downgrades
FBRX - Analyst downgrades
Forte Biosciences Inc. (FBRX) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for FBRX
- Forte Biosciences downgraded by Brookline CapitalBrookline Capital downgraded Forte Biosciences from Buy to Hold
- Forte Biosciences downgraded by Ladenburg ThalmannLadenburg Thalmann downgraded Forte Biosciences from Buy to Neutral
- Forte Biosciences downgraded by Chardan Capital Markets with a new price targetChardan Capital Markets downgraded Forte Biosciences from Buy to Sell and set a new price target of $4.00 from $105.00 previously
- Forte Biosciences downgraded by Truist with a new price targetTruist downgraded Forte Biosciences from Buy to Hold and set a new price target of $4.00
- Forte Biosciences downgraded by B. Riley Securities with a new price targetB. Riley Securities downgraded Forte Biosciences from Buy to Neutral and set a new price target of $3.00
- Forte Biosciences downgraded by Truist SecuritiesTruist Securities downgraded Forte Biosciences from Buy to Hold